share_log

JMP Securities Maintains Market Outperform on Bicycle Therapeutics, Lowers Price Target to $32

Benzinga ·  Dec 20, 2023 07:06

JMP Securities analyst Reni Benjamin maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Market Outperform and lowers the price target from $44 to $32.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment